May 1, 2019
Jamie Blundell, President & COO is pleased to provide the following update on Vireo Health, one of CGOC’s public holdings:
Vireo Health International Inc. (“Vireo”) (CSE: VREO), one of CGOC’s public portfolio holdings, announced fourth quarter and full year financial results for the period ending December 31, 2018, within their earnings release issued yesterday, April 30, 2019 (to read the full press release click here).
Vireo management hosted a conference call with research analysts on Tuesday, April 30, 2019, at 8:30 a.m. ET to discuss its financial results for Q4 and FY ended December 31, 2018. A live audio webcast of this event is available in the Events & Presentations section of the Company’s Investor Relations website or by following this link and will be archived for one year.
Sign up here to be included in our email blasts and receive timely updates.
For further information please contact Cannabis Growth Opportunity Corporation:
|Website: www.cgocorp.com||Investor Relations Email: firstname.lastname@example.org|
Vireo Health International, Inc. is America’s leading science-focused, multi-state cannabis company. Vireo’s physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently has operations in eight states including Arizona, Maryland, Minnesota, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island.
For more information about the company, please visit www.vireohealth.com.